Microvascular Therapeutics, LLC
- Medical device or technology
Microvascular Therapeutics (MVT) is a world leading company in theranostics and ultrasound contrast agents. MVT’s patented, improved ultrasound contrast agent, CardiSon, is poised for near term approval. MVT’s theranostic products have filed pre-IDE’s with FDA and treat deep vein thrombosis, myocardial infarction, cancer and neurodegenerative disease. MVT has its own GMP manufacturing facility.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}